Page last updated: 2024-10-30

memantine and Neuronal Ceroid-Lipofuscinoses

memantine has been researched along with Neuronal Ceroid-Lipofuscinoses in 2 studies

Neuronal Ceroid-Lipofuscinoses: A group of severe neurodegenerative diseases characterized by intracellular accumulation of autofluorescent wax-like lipid materials (CEROID; LIPOFUSCIN) in neurons. There are several subtypes based on mutations of the various genes, time of disease onset, and severity of the neurological defects such as progressive DEMENTIA; SEIZURES; and visual failure.

Research Excerpts

ExcerptRelevanceReference
"Currently there is no treatment for juvenile Batten disease, a fatal childhood neurodegenerative disorder caused by mutations in the CLN3 gene."1.38Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease. ( Cooper, JD; Kovács, AD; Pearce, DA; Ramji, S; Saje, A; Wong, A, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Finn, R1
Kovács, AD2
Pearce, DA2
Saje, A1
Wong, A1
Ramji, S1
Cooper, JD1

Other Studies

2 other studies available for memantine and Neuronal Ceroid-Lipofuscinoses

ArticleYear
Treatment of the Ppt1(-/-) mouse model of infantile neuronal ceroid lipofuscinosis with the N-methyl-D-aspartate (NMDA) receptor antagonist memantine.
    Journal of child neurology, 2013, Volume: 28, Issue:9

    Topics: Animals; Disease Models, Animal; Disease Progression; Excitatory Amino Acid Antagonists; Memantine;

2013
Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease.
    Neuropharmacology, 2012, Volume: 63, Issue:5

    Topics: Aging; Animals; Cerebral Cortex; Disease Models, Animal; Disease Progression; Dose-Response Relation

2012